| |
|
|
Session 49
Poster Presentations Vaccines: Clinical Studies Tuesday 1:30 - 3:30 pm Hall D |
| 401 | Molecular Epidemiology of HIV-1 Among Northern Thai Drug Users: Implications for HIV Vaccine Efficacy Trials C. Beyrer1, S. Tovanabutra*2, V. Suriyanon3, J. Juttiwutikarn4, M. H. Razak5, D. D. Celentano1, D. Birx6, F. McCutchan2 1Johns Hopkins Univ, Baltimore, MD; 2Henry M Jackson Fndn, Rockville, MD; 3Chiang Mai Univ, Thailand; 4Thai Ministry of Hlth, Bangkok, Thailand; 5Joint United Nations Prgrm on HIV and Aids (UNAIDS), Bangkok, Thailand; and 6Walter Reed Army Inst for Res, Rockville, MD |
| 402 | Early Markers of HIV-1 Disease Progression in a Prospective Cohort of Seroconverters in Bangkok, Thailand: Implications for Vaccine Trials K. Buchacz *1, D. Hu 1, S. Vanichseni 2, T. Chaowanachan 3, L. Srisuwanvilai 4, P. Mock3, D. Kitayaporn 5, F. van Griensven 3, J. Tappero 3, J. Keawkungwal 5, K. Choopanya2, T. Mastro 1 1CDC, Atlanta, GA; 2Bangkok Vaccine Evaluation Group, Thailand; 3Thailand MOPH-U S CDC Collaboration, Nonthaburi; 4Bangkok Metropolitan Admin, Thailand; and 5Mahidol Univ, Bangkok, Thailand |
| 403 | Vaccine-induced Positive HIV Serology Among Participants in 10 Clinical Trials of Canarypox-vectored HIV Vaccine Trials in the U.S. P. Sullivan*1, T. Rossini2, G. deBruyn2, N. Russell1, Y. Chiu1, R. Belshe3, M. Keefer4, S. Guranathan5, D. Eastman6, the NIAID HIV Vaccine Trials Network1 1Fred Hutchinson Cancer Res Ctr, Seattle, WA; 2Univ of Washington, Seattle; 3St Louis Univ Sch of Med, MO; 4Univ of Rochester Med Ctr, NY; 5Aventis Pasteur, Swiftwater, PA; and 6VaxGen, San Francisco, California |
| 404 | PACTG 326: A Phase I/II Study to Evaluate the Safety and Immunogenicity of Alvac HIV Vaccines Alone and with AIDSVax B/B in Children Born to HIV-infected Mothers: Preliminary Results D. Johnson*1,2, E. McFarland3, P. Muresan4,8, T. Fenton4,8, J. Lambert5, J. McNamara6, E. Hawkins7, P. Bouquin8, J. Read9, S. Estep6, S. Gunurathan10, M. Gurwith11, PACTG 326 Protocol Team12 1Mt Sinai Hosp, Chicago, IL; 2Chicago Med Sch, IL; 3Univ of Colorado Hlth Sci Ctr, Denver; 4Harvard Sch of Publ Hlth, Boston, MA; 5Univ of Maryland Inst of Human Virology, Baltimore, MD; 6Natl Inst of Allergy and Infectious Diseases, NIH, Bethesda, MD; 7Social and Sci Sys, Silver Spring, MD; 8Frontier Sci and Tech Res Fndn, Chestnut Hill, MA; 9Natl Inst of Child Hlth and Human Dev, NIH, Bethesda, MD; 10Aventis Pasteur, Swiftwater, PA; 11VaxGen, Brisbane, CA; and 12Natl Inst of Allergy and Infectious Diseases/NICHD, NIH, Bethesda, MD |
| 405 | Vaccination in Humans Generates Broad T-cell Cytokine Responses S. C. De Rosa*1, F. X. Lu2, S. P. Perfetto1, S. Moser2, C. J. Miller2, T. G. Evans2, M. Roederer1 1Vaccine Res Ctr, Natl Inst of Hlth, Bethesda, MD and 2Univ of California at Davis |
| 406 | Improving the Quality of the CTL Response with Peptide Mimetopes of an HIV Native Epitope J. Kan-Mitchell*1, D. B. Wilson2, C. R. Rinaldo3, R. Hegde1, T. Cao1, S. Blondelle2, C. Wong3 1Wayne State Univ Sch of Med, Detroit, MI; 2Torrey Pines Inst of Molecular Studies, San Diego, CA; and 3Univ of Pittsburgh, PA |